HDAC9 and amyotrophic lateral sclerosis: Histone deacetylase (HDAC) inhibitors: Several gene analysis studies have discovered distinct gene expression profiles in ALS patients [69–70], indicating that transcriptional dysfunction may contribute to ALS pathology [71].